Novamind is adding a second Client Care Center as it expands its clinic network from four to eight locations.
Cybin Granted IRB Approval for Phase II Clinical Trials of its Sublingual Psilocybin Formulation for the Treatment of Major Depressive Disorder
Cybin announces approval to enter its Phase IIa clinical study and defines the scope of the clinical trial.
Petropavlovsk's gold profits soar as third party gold production ramps up
Russian gold miner Petropavlovsk PLC reported that its full-year underlying profits improved after the Co. produced more gold and benefitted from higher prices, although costs did increase.
Why Copper Is Finding Momentum Again
Workers union at BHP Group’s BHP 0.1% operations center in Santiago rejected the company’s final wage offer raising the chances of a strike at the mines, according to the report.
FDA Endorses Psychedelics 'Guided Experience' Model
The FDA has approved the use of MDMA by therapists -- to better prepare them to administer MDMA-assisted psychotherapy.
Forget Tesla Stock. The EV ‘Gold Rush’ Is in Copper.
There is a lot of money to be made in electric vehicles—just not in the stocks of EV makers such as Tesla, according to Greenlight Capital hedge-fund manager David Einhorn.
Gold prices push higher following disappointing U.S. retail sales numbers
The gold market is seeing further gains Friday as U.S. consumers decided to hold on to their cash last month.
MindMed Announces 2021 Q1 Financial Results; Cash Balance of $160m USD ($194m CAD) to Execute on Diverse Clinical Pipeline
MindMed reports a net loss of CAD$14 million for Q1, with US$160 million in cash and a total cash burn for the quarter of CAD$10 million.
Psychedelic Drugs To The Rescue: Professional Sports Turn To Psychedelics
Traumatic Brain Injury is another major treatment market targeted by psychedelics R&D. TBIs are now a health crisis in many professional sports. Opportunity knocks.
Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and Innovation
Numinus fills several key roles including a new Director of Mergers and Acquisitions and a new Chief Communications Officer.
COMPASS Pathways plc announces financial results and business highlights for the first quarter 2021
Compass Pathways highlights for Q1 include two new patents and reports its Phase IIb clinical trial is on track.
Silver is up over 70% in a year. Here’s why experts say it could have further to go
It’s often overlooked in favor of its lustrous cousin gold, but the price of silver has jumped over 70% in the last year, with commodity strategists saying the rally is likely to continue as the global economy reopens.
